drugset / Trial / NCT00821262

Sevoflurane in Cardiac Surgery

NCT00821262

Phase 4 Completed 200 enrolled Vita-Salute San Raffaele University
RandomizedParallel-groupTriple-blindPrevention

Summary

Patients undergoing high risk cardiac surgery (combined CABG and valvular procedures) will be randomized to receive a total intravenous anesthesia or an anesthesia plan with sevoflurane. The investigators want to document whether the cardioprotective properties of volatile agents could translate in an improved outcome after cardiac surgery in high risk patients.

Timeline

Start
2008-09
Primary completion
2011-07
Completion
2011-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule Intravenous
Subject Sevoflurane Other / unclassified